Literature DB >> 10799192

Antimicrobial mesh versus vaginal wall sling: a comparative outcomes analysis.

J M Choe1, K Ogan, B S Battino.   

Abstract

PURPOSE: We prospectively compared transvaginal antimicrobial mesh (MycroMesh*) and anterior vaginal wall slings using an outcomes analysis.
MATERIALS AND METHODS: Between August 1997 and November 1998 we implanted transvaginal slings in 40 consecutive women randomized to a synthetic mesh (20) or vaginal wall (20) group. All patients had documented stress urinary incontinence on preoperative urodynamics. We prospectively compared postoperative outcomes data obtained from pelvic examinations, cough stress test, cotton swab test and validated patient questionnaires using a visual analog scale.
RESULTS: Complete followup was available in all patients. Mean followup was 22 months (range 12 to 27). Stress incontinence was cured in 95% of the mesh and 70% of the vaginal wall group, and pelvic prolapse was cured in 100% and 95%, respectively. Transient de novo urge incontinence was noted in 12.5% of the mesh and 14.3% of the vaginal wall group. Mean postoperative cotton swab angle during Valsalva's maneuver was 20 and 45 degrees for the mesh and vaginal wall groups, respectively. The incidence of urinary retention and tissue erosion was 0% for both groups. The satisfaction rate was 100% and 80% for the mesh and vaginal wall groups, respectively.
CONCLUSIONS: The antimicrobial MycroMesh sling was superior to the vaginal wall sling for correction of stress incontinence and pelvic prolapse with comparatively low morbidity.

Entities:  

Mesh:

Year:  2000        PMID: 10799192

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Nonautologous sling materials.

Authors:  G M Ghoniem; D S Kapoor
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

Review 2.  Mechanical properties of synthetic implants used in the repair of prolapse and urinary incontinence in women: which is the ideal material?

Authors:  Michel Cosson; Philippe Debodinance; Malik Boukerrou; M P Chauvet; Pierre Lobry; Gilles Crépin; Anne Ego
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-07-25

3.  Complications of synthetic graft materials used in suburethral sling procedures.

Authors:  Kwong-Pang Tsui; Soo-Cheen Ng; Yi-Torng Tee; Guang-Perng Yeh; Gin-Den Chen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-10-19

4.  Assessing outcome after a modified vaginal wall sling for stress incontinence with intrinsic sphincter deficiency.

Authors:  Elisabetta Costantini; Luigi Mearini; Ettore Mearini; Cinzia Pajoncini; Federico Guercini; Vittorio Bini; Massimo Porena
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-10-22

Review 5.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Haroon Rehman; Carlos A Bezerra; Homero Bruschini; June D Cody; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

Review 6.  New millennium, new slings.

Authors:  L V Rodríguez; D S Blander; S Raz
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

7.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Lucky Saraswat; Haroon Rehman; Muhammad Imran Omar; June D Cody; Patricia Aluko; Cathryn Ma Glazener
Journal:  Cochrane Database Syst Rev       Date:  2020-01-28

8.  Could the vaginal wall sling still have a role after FDA's warning? the functional outcomes at 20 years.

Authors:  Ester Illiano; Francesco Trama; Alessandro Marchesi; Consuelo Fabi; Stefano Brancorsini; Elisabetta Costantini
Journal:  Ther Adv Urol       Date:  2022-03-07

9.  Use of grafts in pelvic reconstructive surgery.

Authors:  Myung Jae Jeon; Sang Wook Bai
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

10.  A systematic review of outcome and outcome-measure reporting in randomised trials evaluating surgical interventions for anterior-compartment vaginal prolapse: a call to action to develop a core outcome set.

Authors:  Constantin M Durnea; Vasilios Pergialiotis; James M N Duffy; Lina Bergstrom; Abdullatif Elfituri; Stergios K Doumouchtsis
Journal:  Int Urogynecol J       Date:  2018-10-22       Impact factor: 2.894

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.